Medicover AB (publ)
MCOV-B
주식 순위
#3955
Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ)... Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.
주가
$27.03
시가총액
$4.11B
변동 (1일)
0.56%
변동 (1년)
-1.61%
국가
SE
거래 Medicover AB (publ) (MCOV-B)
카테고리
Healthcare
Medicover AB (publ) (MCOV-B)의 발행 주식 수
October 2026 기준 발행 주식 수: 0
Medicover AB (publ)의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 0입니다. October 2026 말 기준 회사는 0주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Medicover AB (publ) (MCOV-B)의 발행 주식 수 기록 (2014 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2025 | 150.70M | 0.38% |
| 2024 | 150.14M | 0.52% |
| 2023 | 149.36M | 0.43% |
| 2022 | 148.72M | 0.25% |
| 2021 | 148.35M | 4.66% |
| 2020 | 141.75M | 6.31% |
| 2019 | 133.34M | 0.00% |
| 2018 | 133.34M | 11.87% |
| 2017 | 119.19M | 25.44% |
| 2016 | 95.01M | -28.74% |
| 2015 | 133.34M | 0.00% |
| 2014 | 133.34M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 222.83M | - |
US
|
|
| - | - |
DE
|
|
| 83.52M | - |
US
|
|
| 350.00M | - |
SA
|
|
| 2.18B | - |
BR
|
